Effect of vagus nerve stimulation in post-traumatic epilepsy and failed epilepsy surgery : preliminary report.

OBJECTIVE Vagus nerve stimulation (VNS) has been used in epilepsy patients refractory to standard medical treatments and unsuitable candidates for resective or disconnective surgery. In this study, we investigated the efficacy of VNS to patients who had refractory result to epilepsy surgery and patients with post-traumatic epilepsy. METHODS We analyzed the effect of VNS in 11 patients who had undergone previous epilepsy surgery and patients with intractable post-traumatic epilepsy associated with brain injury. All patients underwent VNS implantation between October 2005 and December 2006. RESULTS We evaluated seizure frequency before and after implantation of VNS and maximum follow up period was 24 months. In the first 6 months, 11 patients showed an average of 74.3% seizure reduction. After 12 months, 10 patients showed 85.2% seizure reduction. Eighteen months after implantation, 9 patients showed 92.4% seizure reduction and 7 patients showed 97.2% seizure reduction after 24 months. Six patients were seizure-free at this time. CONCLUSION We conclude that the VNS is a helpful treatment modality in patients with surgically refractory epilepsy and in patients with post-traumatic epilepsy due to severe brain injury.

[1]  J. Craig,et al.  Vagal nerve stimulation in patients with refractory epilepsy. Effect on seizure frequency, severity and quality of life , 2000, Seizure.

[2]  Sang Keun Park,et al.  Vagus Nerve Stimulation in Intractable Childhood Epilepsy: a Korean Multicenter Experience , 2007, Journal of Korean medical science.

[3]  G. Morris,et al.  Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center , 2004, Seizure.

[4]  R. Gilmartin,et al.  Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures , 2000, Epilepsia.

[5]  R. Kuzniecky,et al.  Vagus Nerve Stimulation for Treatment of Partial Seizures: 3. Long‐Term Follow‐Up on First 67 Patients Exiting a Controlled Study , 1994, Epilepsia.

[6]  Steven C Schachter,et al.  Vagus nerve stimulation therapy summary: Five years after FDA approval , 2002, Neurology.

[7]  J. Wheless,et al.  Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy , 2002, Neurology.

[8]  H. Buschman,et al.  Vagus nerve stimulation for medically refractory epilepsy: A long-term follow-up study , 2007, Seizure.

[9]  D. Labar,et al.  Vagus Nerve Stimulation: Analysis of Device Parameters in 154 Patients during the Long‐Term XE5 Study , 2001, Epilepsia.

[10]  W. Tarver,et al.  Treatment of Refractory Partial Seizures: Preliminary Results of a Controlled Study , 1992, Pacing and clinical electrophysiology : PACE.

[11]  Wade M. Mueller,et al.  Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy , 1999, Neurology.

[12]  B. Uthman,et al.  Effectiveness of vagus nerve stimulation in epilepsy patients , 2004, Neurology.

[13]  C. Heck,et al.  Vagus nerve stimulation therapy, epilepsy, and device parameters: Scientific basis and recommendations for use , 2002, Neurology.